Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

H-22411: BOTOX® for Peyronie's Disease

This study is currently recruiting participants. (see Contacts and Locations)
Verified November 2016 by Baylor College of Medicine
Sponsor:
Collaborator:
Allergan
Information provided by (Responsible Party):
Mohit Khera, Baylor College of Medicine
ClinicalTrials.gov Identifier:
NCT00812838
First received: December 18, 2008
Last updated: November 7, 2016
Last verified: November 2016
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: January 2018
  Estimated Primary Completion Date: July 2017 (Final data collection date for primary outcome measure)